-
Christopher B. Toomey
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States
Shiley Eye Institute, Department of Ophthalmology, University of California-San Diego, San Diego, California, United States
-
Michael Landowski
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
-
Mikael Klingeborn
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
-
Una Kelly
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
-
John Deans
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
-
Holly Dong
Rinat, Pfizer Inc, South San Francisco, California, United States
-
Ons Harrabi
Rinat, Pfizer Inc, South San Francisco, California, United States
-
Thomas Van Blarcom
Rinat, Pfizer Inc, South San Francisco, California, United States
-
Yik Andy Yeung
Rinat, Pfizer Inc, South San Francisco, California, United States
-
Ruslan Grishanin
Rinat, Pfizer Inc, South San Francisco, California, United States
-
John C. Lin
Rinat, Pfizer Inc, South San Francisco, California, United States
-
Daniel R. Saban
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
Department of Immunology, Duke University Medical Center, Durham, North Carolina, United States
-
Catherine Bowes Rickman
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States
Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States